Back to regulatory watch
Federal RegisterGuidance and regulationPublished Jul 14, 2026

Request for Information, Training and Care Delivery Models for Safe Administration of Potential FDA-Approved Psychedelic Therapies in Ambulatory Clinical Settings

Updated under an hour ago ()

On April 18, 2026, President Trump issued Executive Order (E.O.) 14401, "Accelerating Medical Treatments for Serious Mental Illness", acknowledging that individuals suffering from serious mental illness may not always respond to existing therapies. This request for information (RFI) solicits stakeholder feedback on training and care delivery models that could be used to ensure safe and effective delivery of potential future Food and Drug Administration (FDA)- approved psychedelic drugs, including drugs administered in ambulatory clinic settings, such as health centers and rural health clinics.

Tags
health IT, Notice, Health and Human Services Department
Related exam domains
CISSP 1: Security and Risk Management; CISM 3: Information Security Program
Source record id
2026-14146
First seen by InfoSec Signals
Sep 23, 2026

Source: Federal Register API, Office of the Federal Register, National Archives and Records Administration about this source more from it

Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.